Features
Non-CNV Predictors of Success of Anti-VEGF for AMD
Clarifying the role of biomarkers is important in determining prognostic implications.
By Harkaran S. Rana, DO, Daniel F. Kiernan, MD, FACS
Biosimilar Therapies in the Treatment of Neovascular AMD
Biosimilar drugs could bring significant cost savings to retina therapy.
By Sruthi Arepalli, MD, Aleksandra V. Rachitskaya, MD, FASRS
Real-World vs Clinical Trial Data for Retinal Drug Regimens
A Q&A with Charles C. Wykoff, MD
By Jennifer Ford, senior managing editor
Update on Longer-Acting Anti-VEGF Therapies
An expansive horizon is coming into focus.
By Michael A. Singer, MD, Effie Z. Rahman, MD
Web Exclusives
An Eye on Patient Education
Communication is key but unlocking the right combination of tools isn't always easy.
By Eric Butterman, contributing writer
Departments
CLINICAL TRIAL DOWNLOAD: Data on a Gene Therapy for Dry and Wet AMD
A phase 1 clinical trial program is targeting both disease states.
By Pravin U. Dugel, MD
CODING Q&A: Billing and the New Physician
Start paperwork early to avoid a lapse in payment.
By Suzanne L. Corcoran, COE
NEW PRODUCT APPLICATIONS: Manage Business Operations Efficiently
Platform helps retina practices streamline drug purchasing and inventory management.
By Karen Appold, contributing writer
News
A Summary of the 48th Annual Aspen Retinal Detachment Society Meeting
By Michael Colucciello, MD
Antiviral Drug Should Not Cause Retinal Toxicity
Screening should not be necessary if drug is given in appropriate doses for a short time.
By Jerry Helzner, contributing editor
Coronavirus Delays Pivotal Retinal Trials
Iveric bio and ProQR announce pauses.
By Jerry Helzner, contributing editor
Regeneron, Genentech Extend Anti-VEGF Payment Terms
In response to the COVID-19 pandemic, both companies have temporarily extended physician payment terms for their anti-VEGF purchases from authorized distributors.
By Jerry Helzner, contributing editor
Retinal Physicians Respond to COVID-19
Maximize safety, communicate with patients, utilize technology, and be prepared.
By Laird Harrison, contributing writer
Topcon Offers Free Breath Shields for Slit Lamps
Breath shield could help prevent spread of coronavirus during eye exams.
By Jerry Helzner, contributing editor
SUBSPECIALTY NEWS: New AMD nomenclature, home-based OCT, prior authorizations, effects of missed ophthalmology visits, and more.
By Jerry Helzner, contributing editor
Supplements
WITH OCT, QUALITY MATTERS
The importance of imager training for proper diagnostics
By Darrin Landry, CRA, OCT-C, FOPS
INTEGRATED IMAGING DELIVERS
How integrated data aids efficiency and better patient care
By Eric W. Schneider, MD
THE GOLD STANDARD OF DME TREATMENT
OCT’s role in the diagnosis and management of diabetic eye disease
By SriniVas R. Sadda, MD
TODAY'S OCT PLATFORMS DRIVE PERSONALIZED AMD CARE
OCT is helping retina specialists improve their diagnostic ability in this critical area
By Peter A. Karth, MD, MBA
THE INTEGRAL ROLE OF OCT IN MANAGEMENT OF MACULAR HOLE
OCT surpasses clinical exam as the most sensitive way to diagnose FTMH
By Christina Y. Weng, MD, MBA